Trial Profile
A phase II study of DP-VPA as add-on therapy for the treatment of complex partial seizures.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2015
Price :
$35
*
At a glance
- Drugs DP-VPA (Primary)
- Indications Seizures
- Focus Therapeutic Use
- 20 Apr 2015 New trial record